Action of fibrinogen degradation products and fibrin monomer soluble complexes on platelet aggregation.
D000135:Acid Phosphatase / Q000032:analysis; D000244:Adenosine Diphosphate / Q000494:pharmacology; D000941:Antigens / Q000494:pharmacology*; D001241:Aspirin / Q000494:pharmacology; D001777:Blood Coagulation; D002850:Chromatography, Gel; D003094:Collagen / Q000494:pharmacology; D003956:Dialysis; D004837:Epinephrine / Q000494:pharmacology; D005337:Fibrin / Q000494:pharmacology*; D005340:Fibrinogen; D006358:Hot Temperature; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008970:Molecular Weight; D010728:Phosphoenolpyruvate / Q000494:pharmacology; D010973:Platelet Adhesiveness / Q000187:drug effects*; D011770:Pyruvate Kinase / Q000494:pharmacology; D012995:Solubility; D013917:Thrombin / Q000494:pharmacology
D000941:Antigens; D000244:Adenosine Diphosphate; D010728:Phosphoenolpyruvate; D005337:Fibrin; D005340:Fibrinogen; D003094:Collagen; D011770:Pyruvate Kinase; D000135:Acid Phosphatase; D013917:Thrombin; D001241:Aspirin; D004837:Epinephrine